You searched for T cells - Page 34 of 41

In Depth 9 Apr 2019

Beyond the Lab-Grown Burger: ‘Cellular Agriculture’ is Taking Over the Food Industry

…common animal these emerging companies are trying to replace; it is known for being the most inefficient meat to produce and one of the biggest contributors to global warming. But…

April 9, 2019 - 7 minutesmins - By Clara Rodríguez Fernández

News and Trends 13 Jun 2016

Immunotherapy reaches Breakthrough in eliminating HIV

…system to kill HIV-infected cells, even those ‘laying low’ like CD4+ T-cells. Fig. 1: The formation of resting memory CD4+ T-cell in healthy cells and in HIV-infected cells, where the…

June 13, 2016 - 3 minutesmins - By Denise Neves Gameiro

Best in Biotech 24 Oct 2024

Six biotech companies advancing multiple sclerosis therapies

…currently in phase 2 of development. BTK is a non-receptor tyrosine kinase that regulates the development and signaling of B cells and myeloid cells that are thought to contribute to…

October 24, 2024 - 8 minutesmins - By Willow Shah-Neville

In Depth 1 Feb 2023

The future of cancer treatment: Exploiting cancer’s key vulnerabilities

…across the globe to raise awareness of the disease’s devastating impact and encourage efforts to improve prevention, detection and treatment. Over the past two decades, advances in diagnosis and treatment…

February 1, 2023 - 4 minutesmins - By External Contributor

News and Trends 24 Jul 2018

Celyad’s Donor Cell CAR-T Therapy Gets Closer to the Clinic

…treatment. The Belgian biotech has been cleared to test its CAR-T cell therapy, made from donor cells, in patients with unresectable colorectal cancer in combination with chemotherapy. The technology could…

July 24, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 20 Oct 2022

Spanish research institution to use Elicera Therapeutics’ iTANK platform

…company’s technology platform for arming and enhancing CAR T-cells to meet two of the major challenges CAR T-cell therapies face in the treatment of solid tumors: tumor antigen heterogeneity and…

October 20, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 15 Nov 2016

Red Blood Cells as Cancer Drug Carriers: Market Approval gets Delayed

…starves tumors to death without damaging healthy cells. One of the key advantages is that red blood cells don’t have any genetic material, deeming them safer than other cell therapies….

November 15, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 20 Oct 2022

Sunshine Biopharma acquires Nora Pharma

…demonstrated the effectiveness of Adva-27a at destroying multidrug resistant cancer cells, including pancreatic cancer cells, small-cell lung cancer cells, breast cancer cells, and uterine sarcoma cells. Clinical trials for pancreatic…

October 20, 2022 - 3 minutesmins - By Jim Cornall

induced pluripotent stem cells ipsc Alzheimer's

Podcast 20 Oct 2023

Beyond Biotech podcast 68 – rejuvenation with stem cells

…cells have the ability not only to stay young but also to undergo rejuvenation when forced to age. Clock.bio’s approach is to harness this power of ‘resetting the clock’ in…

October 20, 2023 - 2 minutesmins - By Jim Cornall

News and Trends 14 Feb 2023

Syena created to deliver first-in-class TCR-NK cell therapy

…generation of cell therapy, combining the safety, potency, and scalability of NK cells with the ability of TCRs to target intracellular tumor antigens. The new company’s TCR-NK cell platform is…

February 14, 2023 - 4 minutesmins - By Jim Cornall

News and Trends 6 Apr 2017

Evotec and Sanofi Hit the First Milestone for a Diabetes Cell Therapy

…partnered to jointly develop a beta cell replacement therapy for the treatment of diabetes in a deal that could reach more than €300M in potential milestone payments. Today, the first…

April 6, 2017 - 2 minutesmins - By Melanie De Almeida

News and Trends 9 Dec 2022

Actinium Pharmaceuticals and Columbia University to study Actimab-A in AML patients

…builds on our leading-edge, combination focused development efforts that includes chemotherapy, targeted agents and immune checkpoint inhibitors. We are eager to show that Actimab-A will produce better post-eHSC transplant outcomes…

December 9, 2022 - 4 minutesmins - By Jim Cornall

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: T cells

Beyond the Lab-Grown Burger: ‘Cellular Agriculture’ is Taking Over the Food Industry

Immunotherapy reaches Breakthrough in eliminating HIV

Six biotech companies advancing multiple sclerosis therapies

The future of cancer treatment: Exploiting cancer’s key vulnerabilities

Celyad’s Donor Cell CAR-T Therapy Gets Closer to the Clinic

Spanish research institution to use Elicera Therapeutics’ iTANK platform

Red Blood Cells as Cancer Drug Carriers: Market Approval gets Delayed

Sunshine Biopharma acquires Nora Pharma

Beyond Biotech podcast 68 – rejuvenation with stem cells

Syena created to deliver first-in-class TCR-NK cell therapy

Evotec and Sanofi Hit the First Milestone for a Diabetes Cell Therapy

Actinium Pharmaceuticals and Columbia University to study Actimab-A in AML patients

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!